Resultados de Molina Healthcare por debajo de lo esperado: ¿Qué sucedió?
Superando las expectativas del mercado
Earnings Q2 2024
(En millones de dólares, excepto datos por acción)
Total revenue 9.880 (8.327)
Total operating expenses 9.446 (7.884)
Operating income 434 (443)
Net income 301 (309)
Net income per share - Diluted 5.17 (5.35)
Diluted weighted average shares outstanding 58.2 (57.9)
Cash and cash equivalents 4.354 (4.848)
Investments 4.347 (4.259)
Receivables 3.231 (3.104)
Property, equipment, and capitalized software, net 305 (270)
Total assets 15.185 (14.892)
Long-term debt 2.181 (2.180)
Finance lease liabilities 203 (205)
Total stockholder’s equity 4.843 (4.215)
Share-based compensation 68 (55)
Net cash (used in) provided by operating activities -5 (1.403)
Purchases of investments 594 (924)
Purchases of property, equipment, and capitalized software 54 (63)
Common stock withheld to settle employee tax obligations 56 (59)
Segment Data
Ending Membership by Segment
Medicaid 4.942.000 (4.741.000)
Medicare 251.000 (166.000)
Marketplace 386.000 (269.000)
Total 5.579.000 (5.176.000)
Consolidated
Premium Revenue 9.446 (8.042)
Medical Margin 1.078 (1.004)
MCR 88.6% (87.5%)
Medicaid
Premium Revenue 7.378 (6.485)
Medical Margin 683 (756)
MCR 90.8% (88.3%)
Medicare
Premium Revenue 1.441 (1.044)
Medical Margin 217 (113)
MCR 84.9% (89.2%)
Marketplace
Premium Revenue 627 (513)
Medical Margin 178 (135)
MCR 71.6% (73.7%)
Guidance 2024
Premium revenue 38 B
Adjusted earnings per diluted share 23.50